IRCT201401096710N4已完成未知
Comparison of therapeutic effects of Fenofibrate and Gemfibrozil on Lipid profile in patients withType 2 Diabetes Mellitus
Research deputy of Tabriz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 75 years（—）
- 性别
- All
入选标准
- •type 2 diabetes ;LDL chol <100 mg/dl ,TG>200 mg/dl ; Non HDL chol >130 mg/dl.
- •Exclusion criteria: age<18;hypothyroidisim;BMI >30,pregnancy;Lactation ;Liver failure ;Renal failure (GFR<30); HB A1C >8%.
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Evaluation of efficacy and safety of Fenofibrate in COVID-19 patientsIRCT20220612055149N1Artesh University of Medical Sciences70
已完成
4 期
A CLINICAL TRIAL ON EFFECT OF SINGLE DOSE FENOFIBRATE AS AN ADJUNCT TO PHOTOTHERAPY IN NEONATAL JAUNDICECTRI/2023/03/050811Deepaa S94
已完成
3 期
Fenofibrate in PSCIRCT20200427047225N1Shahid Beheshti University of Medical Sciences30
已完成
3 期
Comparison between the Effect of Fenofibrate and Clofibrate on Term Neonates with Hyperbilirubinemiaeonatal jaundice.Neonatal jaundice from other and unspecified causesIRCT20190708044158N1Babol University of Medical Sciences80
已完成
不适用
Prevention effect of fenofibrate/pioglitazone in obese diabetic patientsNutritional, Metabolic, EndocrineT2DM, obesityPACTR201407000856135faculty of pharmacy, ain shams university60